Abstract 4365309: The association of longitudinal NT-proBNP levels with echocardiographic measurements in heart failure with preserved ejection fraction: Insights from the PURSUIT-HFpEF Registry

Le résumé fourni par la source

Background: Elevated N-terminal pro-brain natriuretic peptide (NT-proBNP) levels during the stable phase are associated with poor prognosis in heart failure with preserved ejection fraction (HFpEF). Serial measurements of NT-proBNP and evaluation of its trends over time provide additional prognostic value, emphasizing the importance of maintaining lower levels of NT-proBNP. Research Questions: In clinical practice, echocardiography is one of the most useful non-invasive modalities for estimating myocardial wall stress in patients with heart failure. However, the specific echocardiographic parameters associated with longitudinal NT-proBNP levels in HFpEF remain poorly understood. Methods: This study analyzed data from the Prospective mUlticenteR obServational stUdy of patIenTs with HFpEF (PURSUIT HFpEF). Patients hospitalized for acute decompensated HF with a left ventricular ejection fraction (LVEF) ≥50% were included. The association between longitudinal NT-proBNP levels and echocardiographic parameters was assessed using linear mixed-effects models, with further stratification by atrial tachyarrhythmias (ATAs) status. Results: Of 1,238 enrolled patients (median age 83 [77, 87] years; 551 [45%] male), 617 patients with longitudinal NT-proBNP data available (407 without ATAs, 210 with ATAs) were analyzed. In patients without ATAs , even after covariates adjusted, NT-proBNP levels were positively associated with left ventricular diastolic diameter (β-coefficient: 1.878 ± 0.736, P<0.001), left ventricular mass index (β-coefficient: 1.467 ± 0.280, P<0.001), left atrial volume index (β-coefficient: 0.795 ± 0.232, P<0.001), E/e’ (β-coefficient: 1.041 ± 0.214, P<0.001), and tricuspid regurgitation pressure gradient (TRPG) (β-coefficient: 0.849 ± 0.261, P<0.001). Conversely, left ventricular ejection fraction was negatively associated (β-coefficient: -1.632 ± 0.607, P<0.001). However, in patients with ATAs, most of these parameters except for E/e’, TRPG, and interventricular septal thickness at end-diastole had no correlation with NT-proBNP levels. Conclusions: In HFpEF patients without ATAs, longitudinal NT-proBNP levels were broadly associated with both structural and functional echocardiographic parameters. However, patients with ATAs showed limited associations.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.